Lipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Year: 2013
Type: article
Abstract: Cardiovascular disease represents the most common cause of death in patients with nonalcoholic fatty liver disease (NAFLD). Patients with NAFLD exhibit an atherogenic dyslipidemia that is characterized by an increased plasma concentration of triglycerides, reduced concentration of high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) particles that are smaller and more dense than normal. The pathogenesis of NAFLD-associated atherogenic dyslipidemia is multifaceted, but many aspects are attributable to manifestations of insulin resistance. Here the authors review the structure, function, and metabolism of lipoproteins, which are macromolecular particles of lipids and proteins that transport otherwise insoluble triglyceride and cholesterol molecules within the plasma. They provide a current explanation of the metabolic perturbations that are observed in the setting of insulin resistance. An improved understanding of the pathophysiology of atherogenic dyslipidemia would be expected to guide therapies aimed at reducing morbidity and mortality in patients with NAFLD.
Source: Seminars in Liver Disease
Authors: Edward Fisher, David Cohen
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: MOLECULAR PHYSIOLOGY OF BILIARY LIPID SECRETION, Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLD, Molecular Regulation of Apoprotein B Degradation, Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2, Lipid-Mediated Control of Acetyl-CoA Metabolism in the Pathogenesis of NAFLD, G923503880
OpenAlex ID: W1964240866
